The World Health Organization warned that artificial sweeteners, used to replace sugar in a vast range of products, do not help in losing weight and can have serious health effects.
According to the United Nations health agency, a systematic review of available evidence "suggests that use of non-sugar sweeteners (NSS) does not confer any long-term benefit in reducing body fat in adults or children.
In addition, results from the review suggest that the long-term use of NSS could increase the risk of type 2 diabetes, cardiovascular diseases, and mortality in adults.
The WHO's director for nutrition and food safety, Francesco Branca, stressed that replacing ordinary sugar with artificial sweeteners "does not help with weight control in the long term".
He added that NSS are not essential dietary factors and have no nutritional value.
The WHO said its new recommendation applied to everyone except individuals with pre-existing diabetes.
It includes all synthetic and naturally occurring or modified sweeteners not classified as sugars found in manufactured foods and beverages or sold on their own to be added to products by consumers.
Among the most widely used sweeteners are acesulfame K, aspartame, advantame, cyclamates, neotame, saccharin, sucralose, stevia, and stevia derivatives, it said.


U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate
Trump Orders Blockade of Sanctioned Oil Tankers, Raising Venezuela Tensions and Oil Prices
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Asian Fund Managers Turn More Optimistic on Growth but Curb Equity Return Expectations: BofA Survey
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Japan Exports to U.S. Rebound in November as Tariff Impact Eases, Boosting BOJ Rate Hike Expectations
Gold and Silver Surge as Safe Haven Demand Rises on U.S. Economic Uncertainty
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Bank of Japan Poised for Historic Rate Hike as Inflation Pressures Persist
RBA Unlikely to Cut Interest Rates in 2026 as Inflation Pressures Persist, Says Westpac
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools 



